Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells

Human neuroblastoma (NB), a pediatric tumor inclined to relapse, after an initial response to therapy, usually develops resistance. Since several chemotherapeutics exert anticancer effect by increasing reactive oxygen species (ROS), NB cells overproduce antioxidant compounds becoming drugs-resistant...

Full description

Bibliographic Details
Main Authors: Silvana Alfei, Barbara Marengo, Guendalina Zuccari, Federica Turrini, Cinzia Domenicotti
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/10/6/1243
_version_ 1797564101665226752
author Silvana Alfei
Barbara Marengo
Guendalina Zuccari
Federica Turrini
Cinzia Domenicotti
author_facet Silvana Alfei
Barbara Marengo
Guendalina Zuccari
Federica Turrini
Cinzia Domenicotti
author_sort Silvana Alfei
collection DOAJ
description Human neuroblastoma (NB), a pediatric tumor inclined to relapse, after an initial response to therapy, usually develops resistance. Since several chemotherapeutics exert anticancer effect by increasing reactive oxygen species (ROS), NB cells overproduce antioxidant compounds becoming drugs-resistant. A strategy to sensitize NB cells to chemotherapy involves reducing their antioxidant defenses and inducing ROS overproduction. Concerning this, although affected by several issues that limit their clinical application, antioxidant/pro-oxidant polyphenols, such as gallic acid (GA), showed pro-oxidant anti-cancer effects and low toxicity for healthy cells, in several kind of tumors, not including NB. Herein, for the first time, free GA, two GA-dendrimers, and the dendrimer adopted as GA reservoir were tested on both sensitive and chemoresistant NB cells. The dendrimer device, administered at the dose previously found active versus sensitive NB cells, induced ROS-mediated death also in chemoresistant cells. Free GA proved a dose-dependent ROS-mediated cytotoxicity on both cell populations. Intriguingly, when administered in dendrimer formulations at a dose not cytotoxic for NB cells, GA nullified any pro-oxidant activity of dendrimer. Unfortunately, due to GA, nanoformulations were inactive on NB cells, but GA resized in nanoparticles showed considerable ability in counteracting, at low dose, ROS production and oxidative stress, herein induced by the dendrimer.
first_indexed 2024-03-10T18:52:40Z
format Article
id doaj.art-bf69573ae11645dbbdbb96aed1d1ba31
institution Directory Open Access Journal
issn 2079-4991
language English
last_indexed 2024-03-10T18:52:40Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj.art-bf69573ae11645dbbdbb96aed1d1ba312023-11-20T05:01:35ZengMDPI AGNanomaterials2079-49912020-06-01106124310.3390/nano10061243Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma CellsSilvana Alfei0Barbara Marengo1Guendalina Zuccari2Federica Turrini3Cinzia Domenicotti4Department of Pharmacy (DiFAR), University of Genoa, Viale Cembrano, 16148 Genoa, ItalyDepartment of Experimental Medicine—DIMES, University of Genoa, Via Alberti L.B., 16132 Genoa, ItalyDepartment of Pharmacy (DiFAR), University of Genoa, Viale Cembrano, 16148 Genoa, ItalyDepartment of Pharmacy (DiFAR), University of Genoa, Viale Cembrano, 16148 Genoa, ItalyDepartment of Experimental Medicine—DIMES, University of Genoa, Via Alberti L.B., 16132 Genoa, ItalyHuman neuroblastoma (NB), a pediatric tumor inclined to relapse, after an initial response to therapy, usually develops resistance. Since several chemotherapeutics exert anticancer effect by increasing reactive oxygen species (ROS), NB cells overproduce antioxidant compounds becoming drugs-resistant. A strategy to sensitize NB cells to chemotherapy involves reducing their antioxidant defenses and inducing ROS overproduction. Concerning this, although affected by several issues that limit their clinical application, antioxidant/pro-oxidant polyphenols, such as gallic acid (GA), showed pro-oxidant anti-cancer effects and low toxicity for healthy cells, in several kind of tumors, not including NB. Herein, for the first time, free GA, two GA-dendrimers, and the dendrimer adopted as GA reservoir were tested on both sensitive and chemoresistant NB cells. The dendrimer device, administered at the dose previously found active versus sensitive NB cells, induced ROS-mediated death also in chemoresistant cells. Free GA proved a dose-dependent ROS-mediated cytotoxicity on both cell populations. Intriguingly, when administered in dendrimer formulations at a dose not cytotoxic for NB cells, GA nullified any pro-oxidant activity of dendrimer. Unfortunately, due to GA, nanoformulations were inactive on NB cells, but GA resized in nanoparticles showed considerable ability in counteracting, at low dose, ROS production and oxidative stress, herein induced by the dendrimer.https://www.mdpi.com/2079-4991/10/6/1243Human neuroblastomagallic acid (GA)ROS-mediated anticancer effectpolyester dendrimersdendrimer nanoformulations
spellingShingle Silvana Alfei
Barbara Marengo
Guendalina Zuccari
Federica Turrini
Cinzia Domenicotti
Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
Nanomaterials
Human neuroblastoma
gallic acid (GA)
ROS-mediated anticancer effect
polyester dendrimers
dendrimer nanoformulations
title Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
title_full Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
title_fullStr Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
title_full_unstemmed Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
title_short Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
title_sort dendrimer nanodevices and gallic acid as novel strategies to fight chemoresistance in neuroblastoma cells
topic Human neuroblastoma
gallic acid (GA)
ROS-mediated anticancer effect
polyester dendrimers
dendrimer nanoformulations
url https://www.mdpi.com/2079-4991/10/6/1243
work_keys_str_mv AT silvanaalfei dendrimernanodevicesandgallicacidasnovelstrategiestofightchemoresistanceinneuroblastomacells
AT barbaramarengo dendrimernanodevicesandgallicacidasnovelstrategiestofightchemoresistanceinneuroblastomacells
AT guendalinazuccari dendrimernanodevicesandgallicacidasnovelstrategiestofightchemoresistanceinneuroblastomacells
AT federicaturrini dendrimernanodevicesandgallicacidasnovelstrategiestofightchemoresistanceinneuroblastomacells
AT cinziadomenicotti dendrimernanodevicesandgallicacidasnovelstrategiestofightchemoresistanceinneuroblastomacells